Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Pennsylvania for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Pennsylvania only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Pennsylvania (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Allen Ho (NPI 1922056712)

Field	Value
Entity Type	Individual
Organization	Allen Ho
Address	4060 Butler Pike
City	Plymouth Meeting
State	PA
ZIP	19462
Taxonomy	Ophthalmology Physician
NPI Enumerated	May 4, 2006

Payer Source	Total Paid
Medicare	$6.4M
Medicaid	$0

Key Findings

This provider’s Medicare business is overwhelmingly driven by intravitreal anti-VEGF therapy: J0178 (aflibercept) accounts for $3.2M of Medicare revenue (49.5% of total) and, together with J2778 (ranibizumab, $914.8K, 14.3%) and Q5128 (ranibizumab-eqrn, $794.2K, 12.4%), the top 3 Medicare codes account for 76.2% of this provider’s total Medicare revenue. That concentration indicates the practice’s core service line is high-volume intravitreal injections for retinal disease rather than a broad mix of general ophthalmology procedures.

With total Medicare revenue of $6.4M and no Medicaid billing on file, this provider is effectively a Medicare-focused practice. The absence of Medicaid activity (“none below”) means payer mix exposure is heavily weighted to Medicare reimbursement and referral patterns tied to that population.

Several individual codes place this provider among the highest-volume national peers for specific procedure types: J0178 ranks #40 of 3204 providers (99th percentile) and is described as an "extreme outlier, far above typical national volume for this code," while J2778 ranks #47 of 1208 providers (96th percentile; "notably above typical national volume") and Q5128 ranks #23 of 373 providers (94th percentile; "notably above typical national volume"). These rankings indicate national-level prominence in administering these particular biologic injections rather than typical or modest participation.

Beyond drug administration, the provider shows very high volumes for injection-related procedure and diagnostic imaging codes: 67028 (3.4K claims, $355.2K) ranks #56 of 4255 providers (99th percentile; "extreme outlier") and 92134 (4.9K claims, $155.8K) ranks #55 of 26868 providers (100th percentile; "extreme outlier"). This mix—high injection counts paired with high OCT/retina imaging and procedure counts—is consistent with a service model centered on recurring intravitreal therapy plus regular diagnostic follow-up.

Not all high-revenue drug codes are uniformly exceptional: J2777 (faricimab) generated $499.4K (7.8% of Medicare revenue) but ranks #630 of 2039 providers (69th percentile; described as "typical, unremarkable volume for this code"). This suggests the practice’s prescribing pattern favors certain agents (notably aflibercept and ranibizumab/cimerli) over others, which could reflect clinical preference, formulary dynamics, or supply/access factors.

High evaluation-and-management and exam code volumes further support a sustained patient panel: 92012 (intermediate established eye exam) shows 3K claims and $213.9K revenue, ranking #15 of 17177 providers (100th percentile; "extreme outlier"). The combination of very high exam volumes with concentrated injection revenue points to a high-throughput ambulatory ophthalmology operation managing chronic retinal conditions requiring frequent visits.

Revenue concentration in three codes (accounting for 76.2% of Medicare revenue) creates business sensitivity: changes in utilization patterns, reimbursement policy, or drug selection for J0178, J2778, or Q5128 could have outsized financial impact. For payer or network analysts, this profile flags a service line that is both highly specialized and concentrated, which matters for contracting, capacity planning, and utilization management.

The provider has an established billing history, with NPI enumerated on 2006-05-04 (~20 years ago), indicating long tenure in Medicare billing. Combined with the high national ranks on several procedure and drug codes, the tenure and volume suggest a mature, high-volume ophthalmology practice focused on medical retina services rather than a new or low-volume operation.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

21 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	4,590	$690	$3.2M
J2778	Injection, ranibizumab, 0.1 mg	4,840	$190	$914.8K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	3,660	$220	$794.2K
J2777	Injection, faricimab‑svoa, 0.1 mg	17,220	$30	$499.4K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	3,420	$100	$355.2K
92012	For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any…	3,010	$70	$213.9K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	4,870	$30	$155.8K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	1,100	$90	$100.5K
J3590	Unclassified biologics	20	$2,120	$50.9K
J3490	Unclassified drugs	20	$1,770	$42.4K

Showing 1–10 of 21

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 21 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Pennsylvania Distribution

Allen Ho — 6 of 21 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Pennsylvania

Full comparison — all codes billed, vs. state median

21 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	4	140	830	$690	$865.1K
Q5128	12	20	3,830	$220	$838.7K
J2778	13	70	1,030	$190	$417.1K
J2777	24	100	7,950	$30	$360.2K
J2781	19	20	690	$120	$109.1K
67028	11	180	600	$90	$87.5K
J3590	8	10	40	$1,690	$78K
J7999	79	110	100	$120	$33.3K
67042	16	50	20	$1,100	$31.9K
J3490	101	110	60	$70	$27.9K

Showing 1–10 of 21

Related Providers

Other providers that share a Tax Identification Number (TIN) with Allen Ho, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
The Nemours Foundation	DE	Multi-Specialty Clinic/Center	$0	$172M
The Nemours Foundation	FL	Children's Hospital	$0	$104.9M
The Nemours Foundation	DE	Children's Hospital	$0	$104M
The Nemours Foundation	FL	Multi-Specialty Clinic/Center	$0	$46.2M
Nemours Children's Health, Downtown Orlando, Specialty Care	FL	Multi-Specialty Clinic/Center	$0	$44.4M
Nemours Children's Health, Jacksonville, Specialty Care	FL	Multi-Specialty Clinic/Center	$0	$23.6M
Sedigheh Ebadi	FL	Pediatrics Physician	$0	$10.1M
Children's Health Alliance, LLC	FL	Pediatrics Physician	$0	$9.6M
Alok Bansal	CA	Ophthalmology Physician	$3M	$4.7M
David Reed	MA	Retina Specialist (Ophthalmology) Physician	$7.7M	$0

Nearby Providers

Other providers in the same ZIP code as Allen Ho, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Gemma Services	PA	Psychiatric Residential Treatment Facility	$0	$23.8M
Access Services Inc	PA	Community/Behavioral Health Agency	$0	$8.3M
Omesh Gupta	PA	Ophthalmology Physician	$7.1M	$80
Mitchell Fineman	PA	Ophthalmology Physician	$7M	$0
Michael Klufas	PA	Ophthalmology Physician	$7M	$0
Richard Kaiser	PA	Ophthalmology Physician	$6.6M	$0
Allen Chiang	PA	Ophthalmology Physician	$6.6M	$0
Carl Regillo	PA	Ophthalmology Physician	$6.5M	$0
Yoshihiro Yonekawa	PA	Ophthalmology Physician	$6.4M	$0
James Vander	PA	Ophthalmology Physician	$6.3M	$0

Allen Ho — Billing Profile & Reimbursement Data

Sign up for Allen Ho — Billing Profile & Reimbursement Data policy alerts

Allen Ho — Billing Profile & Reimbursement Data

Sign up for Allen Ho — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References